Ilakkiah Chandran

Ilakkiah Chandran

Auto-generated profile, based on publicly available information

Ilakkiah Chandran

Adult Genetic Epilepsy (AGE) Program University of Toronto Toronto Ontario Canada

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2025 in Epilepsia
Verified
Journal Article
Open access
ASArunan Selvarajah
Arunan Selvarajah
ASAndrea Sabo
Andrea Sabo
CGCarolina Gorodetsky
Carolina Gorodetsky
PMPaula T. Marques
Paula T. Marques
ICIlakkiah Chandran
Ilakkiah Chandran
DADanielle M. Andrade
Danielle M. Andrade
Objective: Dravet syndrome (DS) is a severe developmental and epileptic encephalopathy caused by SCN1A haploinsufficiency in the majority of cases. Caregivers of adults with DS often complain about the loss of previously acquired skills. We set out to explore these perceptions and determine whether abnormalities reported were detectable in validated tests. We also investigated possible correlations between symptoms, age, and exposure to sodium channel blockers (SCBs). Methods: This cross‐sectional, multicenter study used the Vineland Adaptive Behavior Scales, 3rd edition (raw scores) for behavior analyses and Moss–Psychiatric Assessment Schedules checklist to screen for psychiatric symptoms. The Social Communication Questionnaire screened for social communication deficits. Parkinsonian features were evaluated with the modified Unified Parkinson's Disease Rating Scale. For gait evaluation, we validated the use of home videos, using instrumental gait analysis in a subgroup of patients, and then used the home videos for the remainder. Results: A total of 92 patients were enrolled (age range = 18–51 years, mean = 27.93 ± 8.59 years). Sixty percent of caregivers observed a decline in previously acquired skills, including intelligence, speech, interaction with others, ability to climb stairs and walk without support, and hand coordination. Adaptive skills, parkinsonian symptoms, and gait were worse in older patients and those exposed to SCBs for longer periods of time. Fourteen percent of patients screened positive for affective disorders, 11.6% for dementia, and 10.5% for a psychotic disorder. Fifty‐three percent screened positive for social communication deficits. Significance: This is the largest group of adults with DS to be systematically evaluated. They had severe nonseizure symptoms. Older age and longer use of SCBs were associated with worse adaptive skills, gait, and parkinsonism. Some older adults screened positive for depression and dementia. Caregivers identified functional decline in activities of daily living (ADLs). Taken together, the risk of dementia, parkinsonian gait, and decline in ability to perform previously mastered ADLs support that some adults with DS may be developing a neurodegenerative disorder.

23 October 2025 in Epilepsia
Verified
Journal Article
Open access
DADanielle M. Andrade
Danielle M. Andrade
NJNathalie Jetté
Nathalie Jetté
ICIlakkiah Chandran
Ilakkiah Chandran
PPPuja Patel
Puja Patel
GRGuido Rubboli
Guido Rubboli
RNRima Nabbout
Rima Nabbout
Objective: Transition planning in epilepsy is crucial to ensure continuity of care, particularly for adolescents with complex needs, yet global practices remain undefined. The International League Against Epilepsy Transition Task Force (ILAE TTF) aimed to evaluate worldwide practices, barriers, and provider perspectives on transitioning patients with epilepsy from pediatric to adult healthcare systems. Methods: A cross‐sectional, web‐based survey was conducted between August 2021 and March 2024. The 50‐item survey, adapted from validated instruments, was distributed in eight languages through ILAE chapters to health care professionals involved in the care of individuals with epilepsy. This study sought to evaluate the availability of structured transition programs, educational and systemic barriers, and recommendations to improve transition. Descriptive statistics, Fisher's exact tests, and multivariate logistic regression analyses were used to compare responses between adult and child neurologists, as well as by country region and income level. Results: A total of 316 neurologists from 58 countries completed the survey. Only 9% reported structured transition programs both locally and nationally, whereas 59% reported none or were unaware of any. Respondents from the Global South were significantly less likely to report transition programs (odds ratio [OR], 0.16; 95% confidence interval [CI], 0.94–0.27; p < .001). Half of the participants believed pediatric teams should continue follow‐up after transfer. Major barriers included a lack of financial support, limited transition‐specific training, and adult neurologists unfamiliar with childhood‐onset epilepsies. Reported patient‐educational gaps included vocational guidance (73%), reproductive health (60%), and driving (57%). Recommendations to improve transition included integrating transition training into neurology curricula (87%), creating dedicated clinical structures and care networks (87%), establishing joint consultations between pediatric and adult neurologists (86%), and implementing national guidelines (89%). Significance: This study demonstrates that epilepsy transition practices remain fragmented and underdeveloped worldwide, especially in low‐resource settings. Enhanced training, improved clinical infrastructure, and better policy coordination are crucial to facilitate effective and equitable transitions.

14 March 2025 in Epilepsia
Verified
Journal Article
Open access
MRMarlene Rong
Marlene Rong
PMPaula T. Marques
Paula T. Marques
QAQuratulain Zulfiqar Ali
Quratulain Zulfiqar Ali
RMRicardo Morcos
Ricardo Morcos
ICIlakkiah Chandran
Ilakkiah Chandran
DADanielle M. Andrade
Danielle M. Andrade
Objective: Dravet syndrome (DS) is a developmental and epileptic encephalopathy. Diagnosis is clinical, but ~90% of patients have pathogenic variants in SCN1A . ATP6V0C has recently been proposed as a novel candidate gene for epilepsy, with or without developmental delay. Here we describe two adult patients with a clinical diagnosis of DS associated with ATP6V0C variants. Methods: Patients with developmental and epileptic encephalopathies were evaluated by physicians who are experts in DS, and their clinical diagnosis was correlated with genetic findings. A subgroup of those patients with DS but without known genetic causes were evaluated through gene panels, whole exome sequencing, and chromosome microarray. Phenotype was determined by pediatric and adult chart reviews, interviews, and physical examinations. Results: Of 753 patients with DS, two unrelated individuals with classic features of DS during childhood and adulthood were identified with heterozygous de novo missense variants in ATP6V0C (c.319G > C, p.(Gly107Arg) and c.284C > T, p.(Ala95Val), respectively). Both variants were absent in normal populations and computational prediction algorithms suggested deleterious effects on protein structure and/or function. No disease‐causing variants in other genes previously associated with DS were found. Significance: Here we describe two adult patients with Dravet‐like syndrome and pathogenic/likely pathogenic variants in ATP6V0C . We propose that abnormal ATP6V0C function can, at the severe end of the clinical spectrum, be associated with Dravet‐like phenotype. This is relevant, as these patients would not qualify for disease‐modifying antisense nucleotide or gene therapies targeting SCN1A .

5 August 2025 in Epilepsia
Verified
Journal Article
Open access
DADanielle M. Andrade
Danielle M. Andrade
ABAnne T. Berg
Anne T. Berg
ASArunan Selvarajah
Arunan Selvarajah
ASAndrea Sabo
Andrea Sabo
CGCarolina Gorodetsky
Carolina Gorodetsky
KVKette Valente
Kette Valente

10 July 2026 in University of Toronto Journal of Public Health
Verified
Journal Article
Open access
PDF file
ICIlakkiah Chandran
Ilakkiah Chandran
ESEmily Suthaharan
Emily Suthaharan
EOEsohe Ogbomo
Esohe Ogbomo
EGElijah Gyansa
Elijah Gyansa
SSStacie Sammot
Stacie Sammot
Aisha LoftersAisha Lofters
Aisha Lofters
Background: Breast cancer remains the most diagnosed cancer among women worldwide. Black women experience higher mortality rates, are more often diagnosed at advanced stages, and face persistent structural barriers to timely and equitable care. In the context of metastatic breast cancer, these inequities become even more pronounced. Despite this, the lived experiences and unmet care needs of Black women with metastatic disease have not been comprehensively synthesized. This narrative review examines the international literature to better understand these experiences and to identify ongoing gaps in care. Methods: A comprehensive search strategy was developed using OVID Medline and conducted across twelve databases. Peer-reviewed studies published in English that focused on the experiences, perceptions, or care needs of Black women with metastatic breast cancer were included. Editorials, commentaries, and studies not specific to metastatic disease were excluded. Three independent reviewers screened studies at the title, abstract, and full-text stages. Two reviewers completed data extraction and thematic synthesis. Results: Sixty studies met inclusion criteria; most originated from the United States, with additional studies from Canada, the United Kingdom, and several African countries. The included literature was comprised of qualitative studies, quantitative analyses, mixed-methods research, and clinical observational studies. Six interrelated themes emerged: cultural competence, personal beliefs and healthcare trust, healthcare navigation, discrimination and bias, support systems, and financial burden. Across studies, Black women described challenges rooted in structural inequities, limited culturally responsive care, healthcare system complexity, and experiences of discrimination. Conclusion: The experiences of Black women with metastatic breast cancer are shaped by intersecting structural and interpersonal barriers that influence care access, treatment experiences, and support. Evidence remains limited outside of the United States and parts of Africa. Further research is needed to more fully understand these disparities and to inform interventions that address the unmet needs of Black women living with metastatic disease.